Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu

• Status: Completed
• Trial end date: 2015-08-01

Summary

The study is a clinical evaluation of an over the counter (OTC) combination product containing paracetamol (500 mg), dimethindene maleate (1 mg), phenylephrine hydrochloride (10 mg) compared to paracetamol (500 mg) alone in the treatment of nasal congestion, rhinorrhea, sneezing and other symptoms due to upper respiratory tract infection (URTI).

• Phase: Phase 3

Details

• Lead Sponsor: Novartis
• Treatments: Acetaminophen; Dimethindene; Maleic acid; Oxymetazoline; Phenylephrine